US Patent Issued to Memorial Sloan-Kettering Cancer Center on April 14 for "Selective GRP94 inhibitors and uses thereof" (American, Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,725, issued on April 14, was assigned to Memorial Sloan-Kettering Cancer Center (New York).

"Selective GRP94 inhibitors and uses thereof" was invented by Gabriela Chiosis (New York), Pengrong Yan (New York), Pallav Patel (Fresh Meadows, N.Y.), Hardik J. Patel (Kew Gardens, N.Y.), Tony Taldone (Forest Hills, N.Y.), Chenghua Yang (Shanghai), Weilin Sun (Princeton, N.J.) and Stefan O. Ochiana (Chevy Chase, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to novel selective Grp94 inhibitors, compositions comprising an effective amount of such compounds, and methods to treat or prevent a condition, such as cancer, comprising adm...